Annual CFI
$38.41 M
-$11.54 M-23.10%
December 31, 2023
Summary
- As of February 8, 2025, SNSE annual cash flow from investing activities is $38.41 million, with the most recent change of -$11.54 million (-23.10%) on December 31, 2023.
- During the last 3 years, SNSE annual CFI has risen by +$39.81 million (+2837.85%).
- SNSE annual CFI is now -23.10% below its all-time high of $49.95 million, reached on December 31, 2022.
Performance
SNSE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$12.91 M
+$6.01 M+86.97%
September 30, 2024
Summary
- As of February 8, 2025, SNSE quarterly cash flow from investing activities is $12.91 million, with the most recent change of +$6.01 million (+86.97%) on September 30, 2024.
- Over the past year, SNSE quarterly CFI has increased by +$4.65 million (+56.31%).
- SNSE quarterly CFI is now -33.86% below its all-time high of $19.53 million, reached on June 30, 2023.
Performance
SNSE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$33.85 M
+$4.60 M+15.73%
September 30, 2024
Summary
- As of February 8, 2025, SNSE TTM cash flow from investing activities is $33.85 million, with the most recent change of +$4.60 million (+15.73%) on September 30, 2024.
- Over the past year, SNSE TTM CFI has dropped by -$4.56 million (-11.87%).
- SNSE TTM CFI is now -32.22% below its all-time high of $49.95 million, reached on December 31, 2022.
Performance
SNSE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SNSE Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.1% | +56.3% | -11.9% |
| 3 y3 years | +2837.8% | -19.5% | -32.2% |
| 5 y5 years | +10000.0% | -19.5% | -32.2% |
SNSE Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.1% | +126.8% | -33.9% | +458.6% | -32.2% | +123.7% |
| 5 y | 5-year | -23.1% | +126.8% | -33.9% | +108.7% | -32.2% | +122.7% |
| alltime | all time | -23.1% | +126.8% | -33.9% | +108.7% | -32.2% | +122.7% |
Sensei Biotherapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.91 M(+87.0%) | $33.85 M(+15.7%) |
| Jun 2024 | - | $6.91 M(+19.7%) | $29.25 M(-30.1%) |
| Mar 2024 | - | $5.77 M(-30.2%) | $41.87 M(+9.0%) |
| Dec 2023 | $38.41 M(-23.1%) | $8.26 M(-0.6%) | $38.41 M(-16.8%) |
| Sep 2023 | - | $8.31 M(-57.4%) | $46.19 M(-0.4%) |
| Jun 2023 | - | $19.53 M(+744.6%) | $46.40 M(+15.8%) |
| Mar 2023 | - | $2.31 M(-85.6%) | $40.07 M(-19.8%) |
| Dec 2022 | $49.95 M | $16.04 M(+88.4%) | $49.95 M(+26.4%) |
| Sep 2022 | - | $8.52 M(-35.5%) | $39.52 M(+29.5%) |
| Jun 2022 | - | $13.20 M(+8.2%) | $30.52 M(-123.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $12.19 M(+117.3%) | -$130.44 M(-8.9%) |
| Dec 2021 | -$143.12 M(>+9900.0%) | $5.61 M(-1264.3%) | -$143.12 M(-4.0%) |
| Sep 2021 | - | -$482.00 K(-99.7%) | -$149.05 M(-0.2%) |
| Jun 2021 | - | -$147.76 M(>+9900.0%) | -$149.40 M(+8028.4%) |
| Mar 2021 | - | -$487.00 K(+54.1%) | -$1.84 M(+31.0%) |
| Dec 2020 | -$1.40 M(+2547.2%) | -$316.00 K(-62.2%) | -$1.40 M(+29.1%) |
| Sep 2020 | - | -$836.00 K(+320.1%) | -$1.09 M(+333.1%) |
| Jun 2020 | - | -$199.00 K(+282.7%) | -$251.00 K(+382.7%) |
| Mar 2020 | - | -$52.00 K | -$52.00 K |
| Dec 2019 | -$53.00 K(+71.0%) | - | - |
| Dec 2018 | -$31.00 K | - | - |
FAQ
- What is Sensei Biotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual CFI year-on-year change?
- What is Sensei Biotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly CFI year-on-year change?
- What is Sensei Biotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics TTM CFI year-on-year change?
What is Sensei Biotherapeutics annual cash flow from investing activities?
The current annual CFI of SNSE is $38.41 M
What is the all time high annual CFI for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual cash flow from investing activities is $49.95 M
What is Sensei Biotherapeutics annual CFI year-on-year change?
Over the past year, SNSE annual cash flow from investing activities has changed by -$11.54 M (-23.10%)
What is Sensei Biotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SNSE is $12.91 M
What is the all time high quarterly CFI for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly cash flow from investing activities is $19.53 M
What is Sensei Biotherapeutics quarterly CFI year-on-year change?
Over the past year, SNSE quarterly cash flow from investing activities has changed by +$4.65 M (+56.31%)
What is Sensei Biotherapeutics TTM cash flow from investing activities?
The current TTM CFI of SNSE is $33.85 M
What is the all time high TTM CFI for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high TTM cash flow from investing activities is $49.95 M
What is Sensei Biotherapeutics TTM CFI year-on-year change?
Over the past year, SNSE TTM cash flow from investing activities has changed by -$4.56 M (-11.87%)